Top Markets
#1 Tornado Cash Tornado Cash +6.24%
#2 Story Story +4.55%
#3 UnifAI Network UnifAI Network +4.47%
#4 TENDIES TENDIES +3.72%
#5 Dual Dual +2.92%
#6 Seeker Seeker +2.82%
#7 Cash Cat Cash Cat +2.58%
#8 Figure Heloc Figure Heloc +2.55%
#9 HOME HOME +2.38%
#10 Orochi Network Orochi Network +2.35%
Coin of the day
Tornado Cash Tornado Cash
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
CMIC HOLDINGS Co., Ltd. CMIC HOLDINGS Co., Ltd.

CMIC HOLDINGS Co., Ltd.

2309
Pozycja w akcjach #16496
Based in Tokyo, Japan, CMIC HOLDINGS Co., Ltd. serves as a leading provider of... Based in Tokyo, Japan, CMIC HOLDINGS Co., Ltd. serves as a leading provider of extensive services to the pharmaceutical industry within Japan. Its operational framework is structured across five strategic segments: Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO), Contract Sales Organization (CSO), Healthcare, and Innovative Pharma Model. Through its CRO capabilities, the company orchestrates comprehensive clinical trial services, encompassing everything from clinical operations, precise data management, and medical writing to patient recruitment, pharmacovigilance, project leadership, and stringent audit and quality assurance, alongside expert statistical analysis. Additionally, it offers critical consulting expertise in areas like clinical site network development, drug formulation, health economics, market entry strategies, and regulatory navigation, including advice on national health insurance pricing for medical devices and in vitro diagnostics. CMIC's CDMO division is instrumental in drug development and manufacturing, handling commercial supply, contract development, investigational product manufacturing, and specialized tasks such as packaging, labeling, release and stability testing, and technology transfer, bolstered by advanced formulation, process, and analytical development services. The company also operates sophisticated laboratory facilities, delivering bioanalysis, GLP/GMP analysis, and studies on biomarkers, large and small molecules, oligonucleotides, and conducting thorough toxicity, safety pharmacology, and non-clinical assessments. Within its Healthcare segment, CMIC focuses on patient and healthcare support, offering innovative solutions like drug adherence programs, specialized health platforms (harmo, Helc+), extensive prescription drug databases, and personalized health checks (selcheck). Beyond these, its portfolio includes post-marketing surveillance, self-inspection, regulatory affairs consulting, regulatory submissions and correspondence, sales and marketing support, and efficient clinical research coordinating and site management services. Demonstrating its commitment to innovation, CMIC HOLDINGS Co., Ltd. has entered into a strategic partnership with Science 37, Inc. to advance the adoption of decentralized clinical trials, thereby accelerating the progress of new treatment development. The company was originally established in 1985.
Cena akcji
$17.25
Ostatnia synchronizacja: 2024-03-27
Kapitalizacja rynkowa
$291.27M
Zmiana (1 dzień)
-0.46%
Zmiana (1 rok)
0.00%
Kraj
JP
Handel CMIC HOLDINGS Co., Ltd. (2309)

Kategoria

Healthcare
Wskaźnik P/E dla CMIC HOLDINGS Co., Ltd. (2309)
Wskaźnik P/E na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji CMIC HOLDINGS Co., Ltd., obecny wskaźnik P/E (TTM) wynosi 0. Na koniec 2026 wskaźnik P/E wynosił 0.
Historia wskaźnika P/E dla CMIC HOLDINGS Co., Ltd. od 2026 do 2026
Wskaźnik P/E na koniec każdego roku
Rok Wskaźnik P/E Zmień
Za mało danych dla podanych dat.
Wskaźnik P/E dla podobnych firm lub konkurentów
Firma Wskaźnik P/E Różnica wskaźnika P/E Kraj
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 33.14 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 37.80 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 -236.74 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 39.09 -
US
Jak odczytywać wskaźnik P/E?

Wskaźnik Cena/Zysk (P/E) mierzy relację między ceną akcji firmy a jej zyskiem na akcję.
Niski, ale dodatni P/E oznacza firmę osiągającą wysokie zyski względem obecnej wyceny i może być niedowartościowana. Wysoki ujemny (bliski 0) P/E wskazuje na duże straty.

Firmy z P/E powyżej 30 lub ujemnym uznaje się zazwyczaj za "akcje wzrostowe", czyli inwestorzy oczekują wzrostu lub przyszłych zysków.

Firmy z dodatnim P/E poniżej 10 uznaje się za "akcje wartościowe", co oznacza, że są już bardzo dochodowe, ale bez dużego potencjału wzrostu.